| MDR | Multidrug-resistant |
| WHO | World Health Organization |
| SARS-CoV-2 | Severe acute respiratory coronavirus 2 |
| mRNA | Messenger RNA |
| FDA | Food and Drug Administration |
| LLA | Liposomal linolenic acid |
| S. aureus | Staphylococcus aureus |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| H. pylori | Helicobacter pylori |
| P. acnes | Propionibacterium acnes |
| DHA | Docosahexaenoic acid |
| IR | Infrared radiation |
| P. aeruginosa | Pseudomonas aeruginosa |
| K. pneumoniae | Klebsiella pneumoniae |
| MDR-PA | Multidrug-resistant Pseudomonas aeruginosa |
| CNM | Carbon-based nanomaterial |
| GO | Graphene oxide |
| E. coli | Escherichia coli |
| NGO–HA | Nanographene oxide–hyaluronic acid |
| E. faecalis | Enterococcus faecalis |
| C. albicans | Candida albicans |
| ROS | Reactive oxygen species |
| NPs | Nanoparticles |
| B. subtilis | Bacillus subtilis |
| S. epidermidis | Staphylococcus epidermidis |
| L. monocytogenes | Listeria monocytogenes |
| GRAS | Generally Recognized as Safe |
| UV | Ultraviolet |
| PVA | Polyvinyl alcohol |
| PEG | Polyethylene glycol |
| MIC | Minimum inhibitory concentration |
| PEN | Polyethylene naphthalate |
| KrF | Krypton fluoride |
| VRE | Vancomycin-resistant E. faecalis |
| rGO | Reduced graphene oxide |
| PEG | Polyethylene glycol |
| LB | Luria–Bertani |
| MOFs | Metal-organic frameworks |
| PES | Polyethersulfone |
| SEM | Scanning electron microscope |
| PA6 | Polyamide 6 |
| EVA | Ethylene-co-vinyl acetate |
| PEP | Poly(Nisopropylacrylamide166-co-n-butyl acrylate9)-poly(ethyleneglycol)-poly (N-isopropylacrylamide166-co-n-butyl acrylate9) |
| PVDF | Poly(vinylidene fluoride) |
| GOQDs | Graphene oxide quantum dots |
| LPHNPs | Lipid polymer hybrid nanoparticles |
| PLGA | Poly(DL-lactic-co-glycolic acid) |
| Luc | Luciferase gene |
| ASO | Antisense oligonucleotide |
| HCPT | Hydroxycamptothecin |